Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the introduction of the trifluoromethylpyridine moiety, which enhances metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for optimizing lead compounds in treatments targeting inflammatory diseases, cancer, and central nervous system disorders. The tert-butyl carbamate (Boc) group allows for selective protection of amines during multi-step syntheses, enabling controlled reactions and improved yield in complex molecule assembly.